Michael Rowley

6.5k total citations
120 papers, 4.0k citations indexed

About

Michael Rowley is a scholar working on Molecular Biology, Infectious Diseases and Hepatology. According to data from OpenAlex, Michael Rowley has authored 120 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 29 papers in Infectious Diseases and 28 papers in Hepatology. Recurrent topics in Michael Rowley's work include HIV/AIDS drug development and treatment (29 papers), Hepatitis C virus research (23 papers) and Neuroscience and Neuropharmacology Research (14 papers). Michael Rowley is often cited by papers focused on HIV/AIDS drug development and treatment (29 papers), Hepatitis C virus research (23 papers) and Neuroscience and Neuropharmacology Research (14 papers). Michael Rowley collaborates with scholars based in Italy, United States and United Kingdom. Michael Rowley's co-authors include Philip Jones, Sergio Altamura, Paul D. Leeson, Yoshito Kishi, Carlo Toniatti, Frank Narjes, Raffaele De Francesco, Edith Monteagudo, Jesus M. Ontoria and Christian Steinkühler and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Diabetes.

In The Last Decade

Michael Rowley

115 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Rowley Italy	38	1.7k	1.6k	706	616	598	120	4.0k
Mark D. Erion United States	44	3.0k 1.8×	1.3k 0.8×	758 1.1×	524 0.9×	179 0.3×	129	5.4k
Joseph P. Vacca United States	38	2.0k 1.2×	1.8k 1.1×	1.4k 2.0×	317 0.5×	332 0.6×	115	4.8k
Richard Storer United Kingdom	33	2.7k 1.6×	3.9k 2.4×	832 1.2×	165 0.3×	208 0.3×	136	6.2k
Laura De Luca Italy	36	1.5k 0.9×	1.6k 1.0×	1.0k 1.5×	140 0.2×	162 0.3×	170	4.0k
Maria Zappalà Italy	37	1.5k 0.9×	2.7k 1.7×	699 1.0×	380 0.6×	65 0.1×	185	4.6k
Hing L. Sham United States	37	2.1k 1.2×	2.0k 1.3×	870 1.2×	558 0.9×	77 0.1×	134	4.6k
Victor G. Matassa Italy	26	632 0.4×	653 0.4×	456 0.6×	145 0.2×	547 0.9×	60	1.8k
Eric S. Furfine United States	33	1.4k 0.8×	595 0.4×	1.2k 1.7×	242 0.4×	82 0.1×	73	4.3k
Thomas D. Meek United States	33	2.9k 1.7×	854 0.5×	1.4k 2.0×	613 1.0×	71 0.1×	70	5.3k
Stephen W. Kaldor United States	20	1.2k 0.7×	1.4k 0.9×	422 0.6×	310 0.5×	55 0.1×	36	2.6k

Countries citing papers authored by Michael Rowley

Since Specialization

Citations

This map shows the geographic impact of Michael Rowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rowley more than expected).

Fields of papers citing papers by Michael Rowley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Rowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rowley. The network helps show where Michael Rowley may publish in the future.

Co-authorship network of co-authors of Michael Rowley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Rowley. A scholar is included among the top collaborators of Michael Rowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Rowley. Michael Rowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rowley, Michael, Amitkumar Patel, Wendi Zhou, Mark Wong, & Anil B. Seetharam. (2018). Immune Reconstitution Syndrome with Initiation of Treatment of HBV/HIV Co-infection: Activity Flare associated with E antigen Seroconversion. Annals of Hepatology. 18(1). 220–224. 10 indexed citations

Rowley, Michael, J. Quentin Clemens, Jerilyn M. Latini, & Anne P. Cameron. (2011). Simple Cystectomy: Outcomes of a New Operative Technique. Urology. 78(4). 942–945. 22 indexed citations

Monteagudo, Edith, Massimiliano Fonsi, Xiaoyan Chu, et al.. (2010). The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A protease. Xenobiotica. 40(12). 826–839. 12 indexed citations

Ferrigno, Federica, Danila Branca, Olaf Kinzel, et al.. (2009). Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells. Bioorganic & Medicinal Chemistry Letters. 20(3). 1100–1105. 14 indexed citations

Pescatore, Giovanna, Danila Branca, Olaf Kinzel, et al.. (2009). Identification and SAR of novel pyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1). Bioorganic & Medicinal Chemistry Letters. 20(3). 1094–1099. 17 indexed citations

Ontoria, Jesus M., Jonathan C. Cruz, Michael Rowley, et al.. (2009). Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model. Bioorganic & Medicinal Chemistry Letters. 19(11). 3081–3084. 26 indexed citations

Branca, Danila, Mauro Cerretani, Philip Jones, et al.. (2009). Identification of aminoethyl pyrrolo dihydroisoquinolinones as novel poly(ADP-ribose) polymerase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(15). 4042–4045. 14 indexed citations

Pacini, Barbara, Renzo Bazzo, Uwe Koch, et al.. (2009). Cyclic phosphoramidates as prodrugs of 2′-C-methylcytidine. European Journal of Medicinal Chemistry. 44(9). 3765–3770. 25 indexed citations

Orvieto, Federica, Danila Branca, Philip Jones, et al.. (2009). Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(15). 4196–4200. 48 indexed citations

10.

Conte, Immacolata, Claudio Giuliano, Frank Narjes, et al.. (2009). Synthesis and SAR of piperazinyl-N-phenylbenzamides as inhibitors of hepatitis C virus RNA replication in cell culture. Bioorganic & Medicinal Chemistry Letters. 19(6). 1779–1783. 26 indexed citations

11.

Scarpelli, Rita, Annalise Di Marco, Federica Ferrigno, et al.. (2008). Studies of the metabolic stability in cells of 5-(trifluoroacetyl)thiophene-2-carboxamides and identification of more stable class II histone deacetylase (HDAC) inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(23). 6078–6082. 17 indexed citations

12.

Monteagudo, Edith, Silvia Pesci, Marina Taliani, et al.. (2007). Studies of metabolism and disposition of potent human immunodeficiency virus (HIV) integrase inhibitors using¹⁹F-NMR spectroscopy. Xenobiotica. 37(9). 1000–1012. 5 indexed citations

13.

Stansfield, Ian, Immacolata Conte, Giovanni Migliaccio, et al.. (2007). Development of carboxylic acid replacements in indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 17(18). 5143–5149. 25 indexed citations

14.

Jones, Philip, Sergio Altamura, Prasun K. Chakravarty, et al.. (2006). A series of novel, potent, and selective histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(23). 5948–5952. 52 indexed citations

15.

Marco, Stefania Di, Cinzia Volpari, Licia Tomei, et al.. (2005). Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small Molecule Inhibitors Bound to a Novel Allosteric Site. Journal of Biological Chemistry. 280(33). 29765–29770. 135 indexed citations

16.

Crawforth, James, John Atack, Susan M. Cook, et al.. (2004). Tricyclic pyridones as functionally selective human GABAAα2/3 receptor-ion channel ligands. Bioorganic & Medicinal Chemistry Letters. 14(7). 1679–1682. 11 indexed citations

17.

Zimmet, Paul, et al.. (1999). Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes.. PubMed. 22 Suppl 2. B59–64. 89 indexed citations

18.

Collins, Ian, Joseph G. Neduvelil, Michael Rowley, et al.. (1998). Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptor. Bioorganic & Medicinal Chemistry. 6(10). 1731–1743. 10 indexed citations

19.

Collins, Ian, Michael Rowley, Frances Emms, et al.. (1998). 3-(1-Piperazinyl)-4,5-dihydro-1H-benzo[g]indazoles: high affinity ligands for the human dopamine D4 receptor with improved selectivity over ion channels. Bioorganic & Medicinal Chemistry. 6(6). 743–753. 20 indexed citations

20.

Grimwood, Sarah, Janusz J. Kulagowski, Ian M. Mawer, et al.. (1995). Allosteric modulation of the glutamate site on the NMDA receptor by four novel glycine site antagonists. European Journal of Pharmacology Molecular Pharmacology. 290(3). 221–226. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact